Related Experiment Videos
Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen
Abstract:
C-ASWS-M, the alkali-soluble, water-soluble cell wall antigen of Coccidioides immitis mycelia, was evaluated for its vaccine potential in mice. Vaccination with 0.5-, 1.5-, or 3-mg doses of C-ASWS-M in complete Freund adjuvant provided a significant level of protection against intraperitoneal challenge with 1,500 arthroconidia (P < 0.0001 with each dose). Vaccination with 1 mg of C-ASWS-M protected mice against intranasal challenge with 50 (P < 0.05) and 500 (P < 0.01) arthroconidia, but not against intranasal challenge with 1,500 arthroconidia (P > 0.05).
Insights
The Coccidioides immitis cell wall antigen, C-ASWS-M, demonstrated significant vaccine potential in mice. This antigen provided protection against fungal challenge, suggesting its utility in developing a Coccidioides vaccine.
Area of Science:
- Mycology
- Immunology
- Vaccinology
Background:
- Coccidioides immitis is a fungus causing coccidioidomycosis.
- Effective vaccines against coccidioidomycosis are lacking.
- Cell wall antigens are potential targets for vaccine development.
Purpose of the Study:
- To evaluate the vaccine potential of C-ASWS-M, an alkali-soluble, water-soluble cell wall antigen from Coccidioides immitis mycelia.
- To assess the protective efficacy of C-ASWS-M in a murine model.
Main Methods:
- Mice were vaccinated with varying doses (0.5, 1.5, or 3 mg) of C-ASWS-M in complete Freund adjuvant.
- Vaccinated mice were challenged via intraperitoneal and intranasal routes with Coccidioides immitis arthroconidia.
- Protection levels were determined by survival rates and challenge dose.
Main Results:
- Vaccination with C-ASWS-M (0.5, 1.5, or 3 mg) significantly protected mice against a high-dose intraperitoneal challenge (1,500 arthroconidia).
- A 1-mg dose of C-ASWS-M provided significant protection against lower-dose intranasal challenges (50 and 500 arthroconidia).
- Protection was not observed against a high-dose intranasal challenge (1,500 arthroconidia) with 1 mg of C-ASWS-M.
Conclusions:
- C-ASWS-M exhibits significant vaccine potential against Coccidioides immitis infection in mice.
- The antigen confers protection in a dose-dependent manner and against different routes of challenge.
- Further research into C-ASWS-M as a subunit vaccine candidate for coccidioidomycosis is warranted.